Journal List > Prog Med Phys > v.26(4) > 1098483

Kim, Park, Lee, Shin, Wu, and Park: Effect of Low Magnetic Field on Dose Distribution in the Partial-Breast Irradiation

Abstract

The aim of this study is to investigate the effect of low magnetic field on dose distribution in the partial-breast irradiation (PBI). Eleven patients with an invasive early-stage breast carcinoma were treated prospectively with PBI using 38.5 Gy delivered in 10 fractions using the ViewRay system. For each of the treatment plans, dose distribution was calculated with magnetic field and without magnetic field, and the difference between dose and volume for each organ were evaluated. For planning target volume (PTV), the analysis included the point minimum (Dmin), maximum, mean dose (Dmean) and volume receiving at least 90% (V90%), 95% (V95%) and 107% (V107%) of the prescribed dose, respectively. For organs at risk (OARs), the ipsilateral lung was analyzed with Dmean and the volume receiving 20 Gy (V20 Gy), and the contralateral lung was analyzed with only Dmean. The heart was analyzed with Dmean, Dmax, and V20 Gy, and both inner and outer shells were analyzed with the point Dmin, Dmax and Dmean, respectively. For PTV, the effect of low magnetic field on dose distribution showed a difference of up to 2% for volume change and 4 Gy for dose. In OARs analysis, the significant effect of the magnetic field was not observed. Despite small deviation values, the average difference of mean dose values showed significant difference (p<0.001), but there was no difference of point minimum dose values in both sehll structures. The largest deviation for the average difference of Dmax in the outer shell structure was 5.0±10.5 Gy (p=0.148). The effect of low magnetic field of 0.35 T on dose deposition by a Co‐60 beam was not significantly observed within the body for PBI IMRT plans. The dose deposition was only appreciable outside the body, where a dose build‐up due to contaminated electrons generated in the treatment head and scattered electrons formed near the body surface.

References

1. Beitsch PD, Shaitelman SF, Vicini FA. Accelerated partial breast irradiation. J Surg Oncol. 103(4):362–368. 2011.
crossref
2. Alvarez C. Accelerated partial breast irradiation. J Am Coll Surg. 209(6):795–796. 2009.
crossref
3. McIntosh A, Read PW, Khandelwal SR, et al. Evaluation of coplanar partial left breast irradiation using tomotherapy-based topotherapy. Int J Radiat Oncol Biol Phys. 71(2):603–610. 2008.
crossref
4. Kozak KR, Smith BL, Adams J, et al. Accelerated partial-breast irradiation using proton beams: initial clinical experience. Int J Radiat Oncol Biol Phys. 66(3):691–698. 2006.
crossref
5. Wilder RB, Curcio LD, Khanijou RK, et al. A Contura catheter offers dosimetric advantages over a MammoSite catheter that increase the applicability of accelerated partial breast irradiation. Brachytherapy. 8(4):373–378. 2009.
crossref
6. Weed DW, Edmundson GK, Vicini FA, et al. Accelerated partial breast irradiation: a dosimetric comparison of three different techniques. Brachytherapy. 4(2):121–129. 2005.
crossref
7. Stewart AJ, Khan AJ, Devlin PM. Partial breast irradiation: a review of techniques and indications. Br J Radiol. 83(989):369–378. 2010.
crossref
8. Mydin AR, Gaffney H, Bergman A, et al. Does a three-field electron/minitangent photon technique offer dosimetric advantages to a multifield, photon-only technique for accelerated partial breast irradiation? Am J Clin Oncol. 33(4):336–340. 2010.
crossref
9. Bourgier C, Taghian A, Marsiglia H. Three-field electron/minitangent photon technique offer dosimetric advantages to a multifield, photon-only technique for accelerated partial breast irradiation if well implemented. Am J Clin Oncol. 34(6):648. 2011.
crossref
10. Vera R, Trombetta M, Mukhopadhyay ND, et al. Long-term cosmesis and toxicity following 3-dimensional conformal radiation therapy in the delivery of accelerated partial breast irradiation. Pract Radiat Oncol. 4(3):147–152. 2014.
crossref
11. Galland-Girodet S, Pashtan I, MacDonald SM, et al. Long-term cosmetic outcomes and toxicities of proton beam therapy compared with photon-based 3-dimensional conformal accelerated partial-breast irradiation: a phase 1 trial. Int J Radiat Oncol Biol Phys. 90(3):493–500. 2014.
crossref
12. Mutic S, Dempsey JF. The ViewRay system: magnetic resonance-guided and controlled radiotherapy. Semin Radiat Oncol. 24(3):196–199. 2014.
crossref
13. Rubinstein AE, Liao Z, Melancon AD, et al. Technical Note: A Monte Carlo study of magnetic-field-induced radiation dose effects in mice. Med Phys. 42(9):5510–5516. 2015.
crossref
14. Burke B, Ghila A, Fallone BG, et al. Radiation induced current in the RF coils of integrated linac-MR systems: the effect of buildup and magnetic field. Med Phys. 39(8):5004–5014. 2012.
crossref
15. Kirkby C, Stanescu T, Fallone BG. Magnetic field effects on the energy deposition spectra of MV photon radiation. Phys Med Biol. 54(2):243–257. 2009.
crossref
16. Wen Z, Pelc NJ, Nelson WR, et al. Study of increased radiation when an x-ray tube is placed in a strong magnetic field. Med Phys. 34(2):408–418. 2007.
crossref
17. Shen CS. adiation problems in a strong magnetic field. Ann N Y Acad Sci. 257:44–55. 1975.
18. Al-Basheer AK, Sjoden GE, Ghita M. Electron Dose Kernels to Account for Secondary article Transport in Deterministic Simulations. Nucl Technol. 168(3):906–918. 2009.
19. Kim JO, Kim JK. ose equivalent per unit fluence near the surface of the ICRU phantom by including the secondary electron transport for photons. Radiat Prot Dosimetry. 83(3):211–219. 1999.
20. Raaijmakers AJE, Raaymakers BW, Lagendijk JJW. Integrating a MRI scanner with a 6 MV radiotherapy accelerator: dose increase at tissue-air interfaces in a lateral magnetic field due to returning electrons. Phys Med Biol. 50(7):1363–1376. 2005.
crossref
21. Esmaeeli AD, Pouladian M, Monfared AS, et al. Effect of uniform magnetic field on dose distribution in the breast radiotherapy. Int J Radiat Res. 12(2):151–160. 2014.

Fig. 1.
The comparison of dose distribution for (a) with magnet field and (b) without magnet field in the case of PBI patient with a magnet field (B0).
pmp-26-208f1.tif
Fig. 2.
Dose and Volume difference values in PTV for each patients.
pmp-26-208f2.tif
Fig. 3.
The dose distribution in saggital image between (a) with magent field (B0) and (b) without magnet field.
pmp-26-208f3.tif
Table 1.
The average dose volume analysis for PTV.
Analysis With Magnet Without Magnet Difference value p-value
Dmean (Gy) 40.7±0.4 40.6±0.4 0.1±0.1 0.003
Dmin (Gy) 30.4±10.0 28.7±9.6 1.7±1.8 0.011
Dmax (Gy) 44.0±0.5 43.9±0.4 1.0±0.3 0.351
V90% (%) 99.9±0.1 99.5±0.5 0.4±0.4 0.025
V95% (%) 98.9±0.6 98.1±1.2 0.8±0.8 0.01
V107% (%) 39.7±10.7 39.0±10.9 0.7±0.8 0.013
Table 2.
The average dose volume analysis for organs at risk (OARs).
OAR Analysis With Magnet Without Magnet Difference value p-value
Ipsilateral lung Dmean (Gy) 7.7±1.8 7.7±1.8 0.0±0.04 1.000
  V20 Gy (%) 6.8±4.2 6.9±4.3 −0.1±0.2 0.116
Contralateral lung Dmean (Gy) 2.1±1.0 2.2±1.0 −0.1±0.4 0.312
Heart Dmean (Gy) 4.7±3.8 4.6±3.8 0.1±0.3 0.359
  Dmax (Gy) 23.5±11.1 23.1±11.8 0.4±1.8 0.484
  V20 Gy (%) 2.1±3.7 2.1±3.7 0.0±0.01 0.221
Table 3.
The average dose analysis for shell structures.
Structure Analysis With magnet Without magnet Difference value p-value
Inner shell Dmean (Gy) 1.53±0.5 1.49±0.5 0.04±0.01 <0.001
  Dmin (Gy) 0.0±0.0 0.0±0.0 0.0±0.01 0.176
  Dmax (Gy) 42.5±1.8 42.3±1.6 0.2±0.4 0.143
Outer shell Dmean (Gy) 1.17±0.4 1.04±0.4 0.13±0.1 <0.001
  Dmin (Gy) 0.0±0.0 0.0±0.0 0.0±0.01 0.221
  Dmax (Gy) 37.5±13.1 32.5±6.6 5.0±10.5 0.148
TOOLS
Similar articles